Director/PDMR Shareholding

Paris, France and Camberley, UK – 11 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 10 November 2020, Edwin Snape, a Non-Executive Director of the Company, purchased 1,080 ordinary shares of €1/15 each in the Company at a price of £7.15 per share. Following the purchase, Mr Snape is interested in 17,919 ordinary shares representing 0.025% of the issued share capital.

https://novacyt.com/wp-content/uploads/2020/11/Novacyt-Directors-Dealings-RNS-Ed-Snape-ENGLISH_11.11.2020.pdf